908 related articles for article (PubMed ID: 21692969)
1. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy.
Ifuku M; Iseki M; Hidaka I; Morita Y; Komatus S; Inada E
Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969
[TBL] [Abstract][Full Text] [Related]
2. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
Gore M; Sadosky A; Tai KS; Stacey B
Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
[TBL] [Abstract][Full Text] [Related]
4. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia.
O'Connor AB; Noyes K; Holloway RG
J Am Geriatr Soc; 2007 Aug; 55(8):1176-84. PubMed ID: 17661955
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study.
Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J
Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin: new drug. Very similar to gabapentin.
Prescrire Int; 2005 Dec; 14(80):203-6. PubMed ID: 16397976
[TBL] [Abstract][Full Text] [Related]
8. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M
J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms.
Ahn SH; Park HW; Lee BS; Moon HW; Jang SH; Sakong J; Bae JH
Spine (Phila Pa 1976); 2003 Feb; 28(4):341-6; discussion 346-7. PubMed ID: 12590206
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.
Irving G; Jensen M; Cramer M; Wu J; Chiang YK; Tark M; Wallace M
Clin J Pain; 2009; 25(3):185-92. PubMed ID: 19333167
[TBL] [Abstract][Full Text] [Related]
11. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
Sang CN; Sathyanarayana R; Sweeney M;
Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
[TBL] [Abstract][Full Text] [Related]
12. Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment.
Barbarisi M; Pace MC; Passavanti MB; Maisto M; Mazzariello L; Pota V; Aurilio C
Clin J Pain; 2010 Sep; 26(7):567-72. PubMed ID: 20639738
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
Solak Y; Biyik Z; Atalay H; Gaipov A; Guney F; Turk S; Covic A; Goldsmith D; Kanbay M
Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343
[TBL] [Abstract][Full Text] [Related]
15. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia.
Parsons B; Tive L; Huang S
Am J Geriatr Pharmacother; 2004 Sep; 2(3):157-62. PubMed ID: 15561647
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?
Guay DR
Am J Geriatr Pharmacother; 2005 Dec; 3(4):274-87. PubMed ID: 16503325
[TBL] [Abstract][Full Text] [Related]
17. Costs and health resources utilization following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain: a post hoc analysis.
Navarro A; Saldaña MT; Pérez C; Masramón X; Rejas J
Pain Pract; 2012 Jun; 12(5):382-93. PubMed ID: 22004531
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
Backonja MM; Canafax DM; Cundy KC
Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials.
Fan H; Yu W; Zhang Q; Cao H; Li J; Wang J; Shao Y; Hu X
J Clin Pharm Ther; 2014 Aug; 39(4):334-42. PubMed ID: 24806220
[TBL] [Abstract][Full Text] [Related]
20. Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin.
Kirson NY; Ivanova JI; Birnbaum HG; Wei R; Kantor E; Puenpatom RA; Ben-Joseph RH; Summers KH
J Med Econ; 2010; 13(3):482-91. PubMed ID: 20684669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]